•  
  •  
  •  
  •  

2025-11-25 16:13:07

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Cantabil Unveils Autumn-Winter 2025 Collection: Claim Your Moment
  • Crisil Ratings : Data centre operators' revenue to surge 20-22% annually till fiscal 2028
  • Servotech Renewable Granted Patent for CCS2 to GB/T EV Charging Conversion Technology
  • Navi AMC launches first-of-its-kind: Navi Nifty MidSmallcap 400 Index Fund
  • New Year, New Destinations: IndiGo Announces Black Friday Sale

Keywords Selected:  Inspection

Stock Report

  • GMP Inspection by Ministry of Health, Armenia at Alkem's manufacturing facility located at Sikkim, India
  • Shilpa Medicare Ltd receives 8 observations from USFDA for Unit 4 at Jadcherla
  • Lupin Ltd receives 7 observations from USFDA for Goa manufacturing facility
  • NATCO Pharma Ltd receives 7 Observations from USFDA for API unit at Manali, Chennai
  • Solara announces successful closure of US FDA inspection of its Mangalore Facility with continued state of compliance on cGMP
  • Aurobindo Pharma gets 9 observations from USFDA for Unit 2 of Eugia Pharma Specialities Ltd
  • USFDA inspects Unit 1 of Divi's Laboratories Limited
  • Closure of USFDA inspection at Zydus' oncology injectable manufacturing facility in SEZ1, Ahmedabad
  • Lupin Bioresearch Center receives Zero Observations from U.S. FDA after Successful Inspection and Assessment
  • Innova Captab Limited updates on SMDC inspection
  • Biocon Limited updates on GMP inspection by USFDA at its Cranbury, New Jersey facility
  • Lupin gets one observation from USFDA for Somerset, New Jersey manufacturing facility
  • Emcure Pharmaceuticals Ltd completes surveillance inspection by USFDA without any observation
  • Zydus receives EIR for the oncology injectable manufacturing facility in SEZ1, Ahmedabad
  • Jubilant Pharmova announces Completion of Pharmacovigilance Inspection by the USFDA with No Observations
  • Lupin gets 4 observations from USFDA from PAI at Pune Biotech facility
  • USFDA successfully completes inspection at Indoco's API manufacturing facility at Patalganga with zero observations
  • Lupin receives 6 observations from USFDA for Nagpur Injectable facility
  • Tyche Industries Ltd completes GMP inspection by ANVISA
  • USFDA conducts product specific pre-approval inspection at Lupin Ltd's Aurangabad facility
  • Closure of USFDA inspection at Zydus' injectable manufacturing plant at Jarod
  • U.S. FDA Completes Inspection at Biocon Biologics' Facility at Biocon Campus, Bengaluru, India
  • Concord Biotech Limited completes EUGMP inspection at its API facility
  • Concord Biotech Ltd successfully completes Russian GMP insepction at its API facility

Latest Post

  • Cantabil Unveils Autumn-Winter 2025 Collection: Claim Your Moment
  • Crisil Ratings : Data centre operators' revenue to surge 20-22% annually till fiscal 2028
  • Servotech Renewable Granted Patent for CCS2 to GB/T EV Charging Conversion Technology
  • Navi AMC launches first-of-its-kind: Navi Nifty MidSmallcap 400 Index Fund
  • New Year, New Destinations: IndiGo Announces Black Friday Sale


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024